FDA Approved: KLONOPIN — Supplemental Application (H2-Pharma, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Klonopin (clonazepam) from H2-Pharma, LLC. The action updates labeling as part of the supplemental NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Panic Disorder

Drugs mentioned

• KLONOPIN (clonazepam)

Snippet

SUPPL AP for KLONOPIN (CLONAZEPAM)